AACR2020 myvac
B. Mallone et al.
AACR 2020
Download the poster here
Poster Presentation
Performance of neoantigen prediction for the design of TG4050, a patient specific neoantigen cancer vaccine
Par Lucie Larguier|2020-06-22T18:41:41+02:00juin 22nd, 2020|Myvac, Publication, TG4050|Commentaires fermés sur Performance of neoantigen prediction for the design of TG4050, a patient specific neoantigen cancer vaccine
À propos de l'auteur : Lucie Larguier
Articles similaires
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity